
SUPN
USDSupernus Pharmaceuticals Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$55.430
Haut
$57.400
Bas
$54.610
Volume
4.00M
Fondamentaux de l'Entreprise
Capitalisation Boursière
3.2B
Industrie
Drug Manufacturers - Specialty & Generic
Pays
United States
Statistiques de Trading
Volume Moyen
0.82M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
B of A Securities Initiates Coverage On Supernus Pharmaceuticals with Buy Rating, Announces Price Target of $65
B of A Securities analyst Pavan Patel initiates coverage on Supernus Pharmaceuticals with a Buy rating and announces Price Target of $65.
TD Cowen Maintains Buy on Supernus Pharmaceuticals, Raises Price Target to $60
TD Cowen analyst Stacy Ku maintains Supernus Pharmaceuticals with a Buy and raises the price target from $45 to $60.
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system
Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight, Raises Price Target to $65
Piper Sandler analyst David Amsellem upgrades Supernus Pharmaceuticals from Neutral to Overweight and raises the price target from $40 to $65.
Actions Connexes
NPV
Nuveen Virginia Quality Municipal Income Fund
CRVL
CorVel Corp.
YUM
Yum! Brands Inc.
WDI
Western Asset Diversified Income Fund Common Shares of Beneficial Interest
XRX
Xerox Holdings Corporation
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.